海外の経尿道的前立腺切除術のベスト医師 — ページ2

ヒューズ・ヒョン医師は低侵襲手術およびロボット手術を専門としており、患者の回復期間の短縮を支援しています。

• 高いケア基準を保証する認定外科医
• ロボット支援手術の専門家
• スラスキー医療センター（イヒロフ）にて診療

42 年以上の外科経験を持つジョセフ・クラウズナー医師は、大腸、膵臓、消化器系の処置を専門としています。

• ソラスキー医療センター外科部長
• 複雑な外科的介入において豊富な経験を持つ
• 外科診療と革新のリーダー

アヴィ・ベリ医師は、ソラスキー医療センターにて経尿道的前立腺切除術（TURP）を含む前立腺処置を専門としています。

• 様々な泌尿器疾患の治療経験が豊富
• 前立腺疾患に対する包括的なケアを提供
• イスラエル有数の医療センターに勤務

Baris Nuhoglu教授は、イスタンブールの主要病院で前立腺手術を専門とする、_doctor_7348_年以上の経験を持つ非常に熟練した泌尿器科医です。

• 泌尿器科の教授職にあり、豊富な学術的資格を有しています
• 58件の国際的研究を含む100以上の科学出版物の著者
• ビルニ大学病院泌尿器科部長
• 欧州泌尿器科学会およびその他の権威ある組織のメンバー
• 高度な泌尿器科技術および処置を専門としています

ムスタファ・セルカン・アレムダル医師は、メディカル・パーク・アンタルヤ病院コンプレックスにてTUIP（経尿道的前立腺切開術）の手技を専門としており、泌尿器科的介入において豊富な経験を有しています。

• コジャエリ大学医学部卒業
• アクデニズ大学にて腫瘍内科の専門課程を修了
• アクデニズ大学病院にて数年間の臨床経験あり
• 現在はメディカル・パーク・アンタルヤ病院コンプレックスに所属

オズカン・オヌク准教授は、メディカルパーク・バフチェリエヴレル病院にて泌尿器科手術を専門としており、前立腺治療に関する広範な研究を行っています。

• _doctor_9727_年以上の泌尿器科経験
• 泌尿器疾患に関する25本以上の国際的な研究論文を発表
• 前立腺疾患に対する低侵襲技術の専門知識

ニューヨークのメモリアル・スローン・ケタリングがんセンターで研修を受けたナバロ・ビルチェス医師は、キロンサル・マルベーリャ（Quirónsalud Marbella）にて高度な泌尿器科手術を専門としています。

• 2019年よりキロンサル・マルベーリャ泌尿器科ユニット長
• マラガ泌尿器科手術研究所共同設立者
• 下部尿路および骨盤底手術の専門家
• カルロス・ハヤ病院腎移植ユニットメンバー

ジョージ・タイ医師は、ポンデラス・アカデミック病院にて、TUIPを含む低侵襲前立腺手術を専門としています。

• TURPおよびレーザー前立腺手術の専門家
• 患者の快適さと回復を重視
• 腹腔鏡下およびロボット支援泌尿器科手術に精通
• 海外の患者様へエビデンスに基づいたケアを提供

ゼンギン医師は泌尿器科で_doctor_8416_年以上の経験を持ち、現在はロクマン・ヘキム・アカイ病院で勤務しています。

• アンカラ・ディシュカプ研修研究病院での専門トレーニング
• トルコ屈指の医学部であるハジェテペ大学卒
• TUIPを含む前立腺手術における豊富な経験

カディル・オネム教授（Prof. Dr. Kadir Önem）は、サムスンのメディカルパーク病院における泌尿器科教授です。イスタンブール大学で医学博士号を取得し、同大学で泌尿器科の専門研修を修了しました。その後、ベイラー医科大学にて神経泌尿器科、再建泌尿器科、および泌尿器腫瘍学の博士研究員課程を修了しました。成人および小児の複雑な神経泌尿器疾患や再建手術の症例を専門とし、独自の外科的手技を開発しています。

神経因性膀胱および膀胱がんに関する複数の国際的な第III相～第IV相臨床試験において治験責任医師（PI）を務めています。70編以上の論文および著書を執筆しており、複数の医学雑誌の査読委員も務めています。

役職および所属：トルコ泌尿器科学会 西黒海支部支部長（2025年）。国際脊髄損傷学会（ISCoS）予防委員会（2025年）。欧州泌尿器科学会（EAU）神経泌尿器科グループ（2023年～2025年）。国際禁制学会（ICS）神経泌尿器科委員会（2023年～2025年）。国際神経泌尿器科学会（INUS）理事（2023年）。受賞歴：トルコ泌尿器科学会（TUA）（2016年、2017年、2020年、2022年）、国際禁制学会（ICS）（2020年）。

Büyük Anadolu病院にて、前立腺の開腹手術および閉鎖手術を含む泌尿器科処置を専門としています。

• RIRS（レーザーによる腎結石破砕術）の専門家
• 泌尿器がん手術を精密に行う
• 尿失禁および不妊治療に精通

准教授のジェム・バサタックは、Gayrettepe Florence Nightingale病院にて、腹腔鏡下手術に重点を置いた泌尿器科を専門としています。

• イスタンブールÜmraniye教育研究病院にて泌尿器科を専門
• カルス州立病院やÇatalca İlyas Çokay州立病院など、複数の病院での経験
• イスタンブールBilim大学医学部泌尿器科クリニックのメンバー

ドリット・ジルバーマン医師は、イスラエルのシェバ医療センターの上級泌尿器科医です。ロボット支援手術および低侵襲泌尿器科手術のパイオニアであり、腎臓がん、膀胱がん、前立腺がんの治療を専門としています。シェバ医療センターにおけるダヴィンチ・ロボット手術プログラムの立ち上げに貢献しました。フォーブス・イスラエル誌により、国内のベストドクターの一人に選出されています。

• 泌尿器腫瘍学および内視鏡泌尿器科学に関する160以上の科学論文を執筆。
• 米国デューク大学医療センターにてフェローシップ研修を修了。
• ロボット支援前立腺全摘除術、レーザー砕石術、腎温存手術を実施。
• 米国泌尿器科学会、欧州泌尿器科学会、および内視鏡泌尿器科学会の会員。

ヤーコフ・ローレンス医師は、シェバ医療センターの放射線腫瘍科部長です。精密放射線治療と神経腫瘍学を専門としています。ローレンス医師は、膵臓がんの疼痛管理のための腹腔神経叢ラジオサージェリー（放射線外科）の先駆者です。専門分野における最高の名誉の一つであるFASTROの称号を保持しています。

• シェバ医療センターの消化器がんプログラムを主導。
• 脳腫瘍および神経系がんに対する定位放射線外科手術を実施。
• 個別化された放射線プロトコルに関する280以上の科学論文を執筆。
• トーマス・ジェファーソン大学で放射線腫瘍学のフェローシップ研修を修了。

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

当医師は、2017年よりキロンサル・トレビエハ病院（Hospital Quirónsalud Torrevieja）の泌尿器科部長を務める、経験豊富な泌尿器科専門医です。ドイツのヨハネス・グーテンベルク大学で医学学位と専門資格を取得し、2007年以来、広範な臨床経験を積んでいます。専門分野は、腫瘍泌尿器科、前立腺疾患、複雑な尿路疾患など多岐にわたります。

当医師の診療における主要な焦点は、ロボット支援泌尿器科手術であり、特に前立腺がんの手術においてダビンチ手術システムを活用しています。また、『Differentialdiagnose Urologie』の章執筆など学術文献にも貢献しており、国内外の患者に対して質の高い医療を提供することに注力しています。

オズカン医師は、Büyük Anadolu病院にてTUIP（経尿道的前立腺切開術）を用いた前立腺疾患の治療を専門としています。

• 腎臓、尿路、膀胱疾患の治療経験
• 尿失禁管理の専門家
• 包括的な泌尿器科ケアのトレーニングを受けています

Büyük Anadolu病院にて、RIRSおよびTUIPを含む開腹・閉腹前立腺手術を専門としています。

• 泌尿器がん手術および尿失禁治療を実施
• 男性不妊症治療における専門知識
• 低侵襲および従来の前立腺手術の両方に精通

ダニエル・レシュチンスキー医師は、_doctor_9996_年の泌尿器科専門知識を持ち、カロライナ病院でTUIP（経尿道的前立腺切除術）などの低侵襲手術を専門としています。

• 2002年より欧州泌尿器科学会（EBU）認定医
• 腹腔鏡下泌尿器科手術における豊富な経験
• ポーランド泌尿器科学会会員
• ワルシャワ医科大学にて研修

2,500件以上の前立腺フュージョン生検を実施 – チャルニエツキ医師は、カロライナ病院にてロボット療法および局所治療を専門としています。

• 中央ヨーロッパで唯一の包括的な前立腺がん診断およびロボット治療センターを統括
• 米国、オランダ、ドイツのセンターとの国際的な協力関係
• 前立腺がん治療におけるHIFU法の専門家
• 欧州泌尿器科学会委員会の活動メンバー